Difference between revisions of "Louis CU, et al. Annu. Rev. Med. (2015) cited as Ref 229 in DOI: 10.1038/s41392-020-0110-5 (Q9492)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 66, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 49-63, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Neuroblastoma: molecular pathogenesis and therapy (English) | ||
| Property / title: Neuroblastoma: molecular pathogenesis and therapy (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 49-63 | ||
| Property / Page(s): 49-63 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:34, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Louis CU, et al. Annu. Rev. Med. (2015) cited as Ref 229 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Louis CU
0 references
Shohet JM
0 references
2015
0 references
Annu. Rev. Med.
0 references
66
0 references
Neuroblastoma: molecular pathogenesis and therapy (English)
0 references
49-63
0 references
